Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bassetti

Showing results (161-170 of 740) with videos related to

Pageof 74
Sort By:
Current Opinion in Infectious Diseases|February 11, 2026
Tropical infectious diseases and skin manifestations: a diagnostic frameworkGaia Cologgi, Marianna Giurco, Rebecca Donadoni, et al.
Infection and Drug Resistance|April 27, 2026
Innovative Antibiotics: The Experience of Cefiderocol in Carbapenem-Resistant Gram-Negative InfectionsMonica Melchio, Federica Briano, Chiara Sepulcri, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2017
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15)Michael A Pfaller, Matteo Bassetti, Leonard R Duncan, et al.
International Journal of Antimicrobial Agents|May 9, 2009
Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermidis endocarditis and spondylodiscitisMatteo Bassetti, Małgorzata Mikulska, Eva Schenone, et al.
Expert Opinion on Drug Safety|October 11, 2021
Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infectionsMatteo Bassetti, Antonio Falletta, Giovanni Cenderello, et al.
Seminars in Respiratory and Critical Care Medicine|January 28, 2022
New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated PneumoniaMatteo Bassetti, Alessandra Mularoni, Daniele Roberto Giacobbe, et al.
Current Opinion in Critical Care|August 29, 2023
Severe infections caused by difficult-to-treat Gram-negative bacteriaSilvia Dettori, Federica Portunato, Antonio Vena, et al.
Current Opinion in Infectious Diseases|October 17, 2023
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectivesMatteo Bassetti, Nadia Castaldo, Alberto Fantin, et al.
Drugs in Context|June 12, 2020
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemicMatteo Bassetti, Paolo Pelosi, Chiara Robba, et al.
Minerva Anestesiologica|May 12, 2017
Elderly versus non-elderly patients with intra-abdominal candidiasis in the ICUGeorge Dimopoulos, Dimitrios K Matthaiou, Elda Righi, et al.
Pageof 74

Showing results (161-170 of 740) with videos related to

Sort By:
Pageof 74
Current Opinion in Infectious Diseases|February 11, 2026
Tropical infectious diseases and skin manifestations: a diagnostic frameworkGaia Cologgi, Marianna Giurco, Rebecca Donadoni, et al.
Infection and Drug Resistance|April 27, 2026
Innovative Antibiotics: The Experience of Cefiderocol in Carbapenem-Resistant Gram-Negative InfectionsMonica Melchio, Federica Briano, Chiara Sepulcri, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2017
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15)Michael A Pfaller, Matteo Bassetti, Leonard R Duncan, et al.
International Journal of Antimicrobial Agents|May 9, 2009
Long course of daptomycin in the treatment of meticillin-resistant Staphylococcus epidermidis endocarditis and spondylodiscitisMatteo Bassetti, Małgorzata Mikulska, Eva Schenone, et al.
Expert Opinion on Drug Safety|October 11, 2021
Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infectionsMatteo Bassetti, Antonio Falletta, Giovanni Cenderello, et al.
Seminars in Respiratory and Critical Care Medicine|January 28, 2022
New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated PneumoniaMatteo Bassetti, Alessandra Mularoni, Daniele Roberto Giacobbe, et al.
Current Opinion in Critical Care|August 29, 2023
Severe infections caused by difficult-to-treat Gram-negative bacteriaSilvia Dettori, Federica Portunato, Antonio Vena, et al.
Current Opinion in Infectious Diseases|October 17, 2023
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectivesMatteo Bassetti, Nadia Castaldo, Alberto Fantin, et al.
Drugs in Context|June 12, 2020
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemicMatteo Bassetti, Paolo Pelosi, Chiara Robba, et al.
Minerva Anestesiologica|May 12, 2017
Elderly versus non-elderly patients with intra-abdominal candidiasis in the ICUGeorge Dimopoulos, Dimitrios K Matthaiou, Elda Righi, et al.
Pageof 74